Cryoport expands into biostorage with Cryogene acquisition

By Vassia Barba contact

- Last updated on GMT

(Image: Getty/Yozayo)
(Image: Getty/Yozayo)

Related tags: Cryoport, Logistics, cell and gene therapy, CAR-T

Cryoport acquires Cryogene to gain access to the latter company’s 21,000-square-foot biostorage facility in Houston.

The cold chain logistics firm for the life sciences industry has been looking to add storage services to its offering, Mark Sawicki, Cryoport’s CCO told us ​recently.

The acquisition is structured as an asset purchase and, as stated, it is expected to be immediately accretive to Cryoport's earnings.

The US facility provides storage of biological specimens, materials and samples for clients such as Merck, MD Anderson, Houston Methodist Hospital, Texas Children's Hospital, Mesoblast, Bellicum and Baylor University.

The storage service for biological commodities covers a full range of temperatures, from cryogenic to controlled room temperature, and includes sample inventorying, data sample discrepancy resolution and accessioning samples into its validated data inventory software.

The deal comes after Cryoport expanded the number of its clients recently, including adding Celularity ​to its clients roster.

During the previous year, the company established multiple collaborations ​and boosted its revenue ​by becoming the exclusive distributor of Novartis’ Kymriah​ ​(tisagenlecleucel) and Kite’s Yescarta (axicabtagene ciloleucel), the two approved chimeric antigen receptor (CAR)-T therapies.

Related news

Show more

Related products

Microsampling in Early Phase Drug Development

Microsampling in Early Phase Drug Development

Altasciences | 10-May-2022 | Technical / White Paper

Microsampling significantly lessens the volume of blood and plasma/serum that is collected and analyzed to determine circulating concentrations of therapeutic...

Seasonal Vaccine Manufacturing

Seasonal Vaccine Manufacturing

Baxter BioPharma Solutions | 16-Feb-2022 | Technical / White Paper

The production of seasonal vaccines, such as those for influenza, presents unique challenges to manufacturers due to the necessary time constraints resulting...

Consideration and Options for Prefilled Syringes

Consideration and Options for Prefilled Syringes

Baxter BioPharma Solutions | 16-Feb-2022 | Technical / White Paper

Convenience, product differentiation, and less waste are great reasons for developing a product in a prefilled syringe. Baxter’s whitepaper describes the...

Partner with Experts in Precision Medicine

Partner with Experts in Precision Medicine

CellCarta | 17-Jan-2022 | Product Brochure

At CellCarta, we’re dedicated to working with our partners to further the limitless potential of precision medicine. Our broad technology offering is designed...

Related suppliers